Aegerion Pharmaceuticals, Inc. Announces Presentation at the Cowen and Company 33rd Annual Health Care Conference
Published: Feb 27, 2013
CAMBRIDGE, Mass., Feb. 27, 2013 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating and often fatal rare diseases, announced today that the company will participate in the Cowen and Company 33rd Annual Health Care Conference in Boston. Marc Beer, Chief Executive Officer of Aegerion, is scheduled to present on Monday, March 4, 2013 at 1:30 p.m. ET.